Amicus Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FOLD and other ETFs, options, and stocks.

About FOLD

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. 

CEO
Bradley Lewis Campbell
CEOBradley Lewis Campbell
Employees
499
Employees499
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
2002
Founded2002
Employees
499
Employees499

FOLD Key Statistics

Market cap
1.88B
Market cap1.88B
Price-Earnings ratio
-64.28
Price-Earnings ratio-64.28
Dividend yield
Dividend yield
Average volume
6.16M
Average volume6.16M
High today
$6.16
High today$6.16
Low today
$5.97
Low today$5.97
Open price
$6.01
Open price$6.01
Volume
3.12M
Volume3.12M
52 Week high
$12.65
52 Week high$12.65
52 Week low
$5.51
52 Week low$5.51

FOLD News

TipRanks 2d
Amicus Therapeutics’ Migalastat Study: A Potential Game-Changer for Fabry Disease Treatment

Amicus Therapeutics ((FOLD)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 50...

Analyst ratings

82%

of 11 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

People also own

Based on the portfolios of people who own FOLD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.